128 related articles for article (PubMed ID: 25940995)
41. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
42. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
43. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.
Xu X; Feng L; Liu Y; Zhou WX; Ma YC; Fei GJ; An N; Li Y; Wu X; Yao F; Cheng SJ; Lu XH
World J Gastroenterol; 2014 Dec; 20(47):17883-93. PubMed ID: 25548486
[TBL] [Abstract][Full Text] [Related]
44. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
45. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
46. Juxta-articular myxoma: an unusual benign mesenchymal lesion, readily mistaken for malignancy.
Beggan C; Davies K; Leader M
Ir Med J; 2014; 107(7):212-3. PubMed ID: 25226717
[TBL] [Abstract][Full Text] [Related]
47. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.
Huang HY; Wu WR; Wang YH; Wang JW; Fang FM; Tsai JW; Li SH; Hung HC; Yu SC; Lan J; Shiue YL; Hsing CH; Chen LT; Li CF
Clin Cancer Res; 2013 Jun; 19(11):2861-72. PubMed ID: 23549872
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathologic features of cardiac myxoma--a report of 47 cases].
Wang HY; Zhang XB; Zheng JJ; Deng Y; Wang YL; Song YX; Liu L; Wang M
Ai Zheng; 2006 Jul; 25(7):892-5. PubMed ID: 16831285
[TBL] [Abstract][Full Text] [Related]
49. Cell cycle regulators and apoptosis-associated proteins in relation to proliferative activity and degree of apoptosis in HNPCC versus sporadic endometrial carcinoma.
Rijcken F; van der Zee A; van der Sluis T; Boersma-van Ek W; Kleibeuker J; Hollema H
Histopathology; 2006 Feb; 48(3):275-85. PubMed ID: 16430474
[TBL] [Abstract][Full Text] [Related]
50. Cell cycle protein expression and proliferative status in human corneal cells.
Joyce NC; Meklir B; Joyce SJ; Zieske JD
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):645-55. PubMed ID: 8595965
[TBL] [Abstract][Full Text] [Related]
51. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
52. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
53. Cardiac myxoma with glandular elements: a clinicopathological and immunohistochemical study of five new cases with an emphasis on differential diagnosis.
Zhang M; Ding L; Liu Y; Xue L
Pathol Res Pract; 2014 Jan; 210(1):55-8. PubMed ID: 24238992
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical selection of biomarkers for tumor-targeted image-guided surgery of myxofibrosarcoma.
de Gooyer JM; Versleijen-Jonkers YMH; Hillebrandt-Roeffen MHS; Frielink C; Desar IME; de Wilt JHW; Flucke U; Rijpkema M
Sci Rep; 2020 Feb; 10(1):2915. PubMed ID: 32076024
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
56. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours.
Wharton SB; Hibberd S; Eward KL; Crimmins D; Jellinek DA; Levy D; Stoeber K; Williams GH
Br J Cancer; 2004 Jul; 91(2):262-9. PubMed ID: 15199392
[TBL] [Abstract][Full Text] [Related]
57. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
58. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
59. [Myxofibrosarcoma].
Kirchner T; Wünsch PH
Zentralbl Allg Pathol; 1983; 128(3-4):207-15. PubMed ID: 6666408
[TBL] [Abstract][Full Text] [Related]
60. The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives.
Sambri A; De Paolis M; Spinnato P; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(6):314-322. PubMed ID: 32450554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
